Malvern, UK 7/25/14—Malvern Instruments has acquired the Archimedes particle-characterization system, including intellectual property and the license to the underlying MIT patent, from Affinity Biosensors for an undisclosed amount. The Archimedes system utilizes Resonant Mass Measurements to detect and count particles. Malvern has exclusively distributed the product outside North America since 2012 (see IBO 11/30/12). “Affinity […]
Billerica, MA 7/28/14—Bruker has acquired Vutara, a provider of high-speed, 3D, super-resolution fluorescence microscopy for life science applications, for an undisclosed amount. Vutara is estimated to have 2014 revenues of $2 million. Bruker stated that the acquisition adds super-resolution and single-molecule localization microscopy products to its multiphoton scanning confocal fluorescence-microscopy product line. “Achieving video-rate time […]
Warren, NJ 7/17/14—Roka Bioscience, a provider of testing solutions for detecting foodborne pathogens, has completed its IPO (see IBO 5/31/14, 7/15/14), offering five million shares at a price of $12.00 per share. Shares began trading on the NASDAQ Global Market on July 17 under the ticker symbol “ROKA.” The company has granted the underwriters a […]
Milford, MA 7/22/14; Budapest, Hungary 7/22/14—Waters has acquired Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology, which represents substantially all the assets of Hungarian start-up company MediMass. REIMS can be used as an ambient ionization source for MS. Waters plans to commercialize a REIMS ion source for its TOF-MS systems. In addition, Waters plans to continue […]
Männedorf, Switzerland 7/30/14—Tecan has agreed to acquire German firm IBL International, a provider of microtiter-plate–based imunoassays for specialty diagnostics for use in research and clinical labs, for €29.0 million ($39.2 million = €0.74 = $1). In 2013, IBL had revenues of €16 million ($21 million = €0.75 = $1). “As part of our strategy, this […]
San Diego, CA 7/16/14—Illumina has purchased Myraqa, a regulatory and quality consulting firm that specializes in IVD, particularly companion diagnostics. The purchase price was undisclosed. Illumina stated that the acquisition adds to its in-house capabilities for clinical readiness and prepares it for its next growth phase in regulated markets. “With Myraqa, Illumina will continue to […]
Washington, DC 7/23/14—Bruker has announced in an SEC filing that it plans to divest certain assets of its Chemical & Applied Markets Division (CAM) and restructure the unit. In 2013, CAM had revenues of $100 million. Bruker stated that it plans to divest or restructure CAM’s GC product lines, including its single-quadrupole GC and GC/MS […]
Waltham, MA 7/17/14; Chicago, IL 7/17/14—Private-equity firm GTCR has agreed to buy Thermo Fisher Scientific’s Cole-Parmer Instrument business (see IBO 5/31/14), part of its Laboratory Products and Services Segment, for $480 million in cash. Based in Illinois with 400 employees, Cole-Parmer is a manufacturer and distributor of laboratory supplies, specializing in fluid-handling, test and measurement, […]
Washington, DC 7/7/14—In a new filing with the SEC, Roka Bioscience provided additional details of its pending IPO (see IBO 5/31/14). The company plans to offer five million shares of common stock at a price of $14–$16 per share. Net proceeds are estimated to be $67.4 million, or $77.8 million if the overallotment option is […]
Omaha, NB 7/2/14; Coralville, TA 7/2/14—Transgenomic has agreed to sell the rights to its SURVEYOR Nuclease technology and the assets to Integrated DNA Technologies (IDT) for a minimum of $4.25 million, including an upfront payment of $3.65 million. Transgenomic will exclusively sublicense rights for SURVEYOR clinical and diagnostic applications from IDT. SURVEYOR Nuclease recognizes and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
